• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol . Analysis of the positive rate of 4254 cases of COVID-19 nucleic acid tests in Different Sites in Wuhan, China

tetano

Editor, Senior Moderator
J Med Virol


. 2020 Jul 21.
doi: 10.1002/jmv.26323. Online ahead of print.
Analysis of the positive rate of 4254 cases of COVID-19 nucleic acid tests in Different Sites in Wuhan, China


Kebin Deng[SUP] 1 [/SUP], Hui Li[SUP] 1 [/SUP], Xin Ma[SUP] 1 [/SUP], Bianbian Yu[SUP] 1 [/SUP], Xinlin Yi[SUP] 1 [/SUP], Ying Chen[SUP] 1 [/SUP], Bo Tian[SUP] 1 [/SUP], Qing Zhang[SUP] 2 [/SUP]



Affiliations

Abstract

Background: There's an outbreak of COVID-19 since December 2019, first in Wuhan. It has caused huge medical challenges to Hubei Province with currently more than 67 thousand confirmed cases till March 08, 2020. Identification, there is no clinically effective drug. Isolation and masks are essential to limit human-to-human transmission initially. The nucleic acid test (NAT) of COVID-19 currently was the most reliable established laboratory diagnosis method in clinical.
Methods: From February 8th, 2020 to March 7th, 2020, 4254 cases were collected for analysis at six nucleic acid collection sites in the community medical team of Hubei Provincial Hospital of Traditional Chinese Medicine, which cover almost all groups who need NAT in Wuhan. Distribution of positive rates in different sites by genders, ages or occupations were compared.
Results: The positive rates of different sites from high to low were: hospital wards (24.71%) > fever clinics (16.57%) > nursing homes (5.51%) > isolation hotels (5.30%) > rehabilitation stations (1.36%) > close contact sites (0.17%). The confirmed patients in isolation hotels, hospital ward and fever clinical were mainly middle-aged and elderly, and most of them were women. The positive rate in isolation hotels and fever clinics gradually decreased over time. There were no significant differences between genders among those six nucleic acid collection sites (P <0.05).
Conclusions: The hospital wards have the highest positive rate; however, close contact sites have lowest one. Patients who are discharged from hospitals may still have potential risks. Middle-aged and older people remain the focus of epidemic prevention and control. This article is protected by copyright. All rights reserved.

Keywords: COVID-19; novel coronavirus pneumonia; nucleic acid test; positive rate.
 
Back
Top Bottom